-
Exclusive Interview | Academician Yuming Lu : The Application of Liquid Biopsy Based on Plasma DNA Fragmentomics in Early Cancer Screening
Liquid biopsy is a cutting-edge technology that utilizes molecular biomarkers in human body fluids for analysis, thereby obtaining relevant disease information. In the era of precision medicine, liquid biopsy has become an indispensable tool in the field of tumor diagnosis and treatment. It has received extensive attention and research for its applications in early tumor…
-
BISC 2024 | Professor Yunsong Yu: The Current Epidemic Situation and Challenges of CRO Infections in China
In recent years, the detection rate of carbapenem-resistant Gram-negative bacteria (CRO) in China has remained high, posing serious challenges to clinical treatments and patient outcomes. The limited therapeutic options have left many clinical needs unmet. At the recent Fourth National Conference on Bacterial and Fungal Infections organized by the Chinese Medical Association (BISC 2024), Professor…
-
Professor Rong Fan: Precision Screening for Liver Cancer Patients in China
Primary liver cancer is currently the fourth most common malignant tumor and the second leading cause of cancer death in China, posing a serious threat to the health and well-being of the population. Reducing the burden associated with liver cancer remains a major challenge in the fields of public health and chronic disease prevention in…
-
Professor Chunrong Ju Provides a Comprehensive Overview of IFD Diagnosis and Treatment Strategies in SOT Recipients at BISC 2024
Solid Organ Transplantation (SOT) is a crucial procedure for saving the lives of patients with end-stage organ failure. In recent years, the field of SOT has flourished in China, with significant improvements in the number of transplants and treatment outcomes. However, infections remain a critical factor affecting the survival and quality of life of SOT…
-
Professor Yujie Wu: Standardized Flow Cytometry Detection of CLL-MRD | The 15th Experimental Diagnostic Hematology Conference of the Chinese Medical Association and the 1st Conference on Rare Blood Diseases
As spring blossoms and nature revives, the 15th Experimental Diagnostic Hematology Conference and the 1st Conference on Rare Blood Diseases, hosted by the Chinese Medical Association, were grandly held in the city of Gusu on March 23-24, 2024. The conference invited renowned experts and scholars from the field of hematology both domestically and internationally to…
-
Dr. Jimmy Che-To LAI, two award winners, talks about the 2024 APASLAnnual Meeting
From March 27 to 31, 2024, the 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2024) was held in Kyoto, Japan. As a top international conference, this year’s APASL annual meeting brings together a large number of the latest research progress. After the feast, the heat did not…
-
Dialogue Interview丨Dr. Jacob George & Dr. Xiaolong Qi discuss frontier hotspots of Metabolic Associated Fatty Liver Disease
The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2024) was held in Kyoto, Japan from March 27 to 31, 2024. Metabolic-associated fatty liver disease (MAFLD) was one of the hot topics in the congress. MAFLD has become a common chronic liver disease worldwide and is caused by…
-
Professor Shunqing Wang: Optimizing SAA Hematopoietic Stem Cell Transplantation to Improve Survival and Quality of Life for More Patients | The 19th National Conference on Red Blood Cell Disorders (Anemia) by the Chinese Medical Association
Severe aplastic anemia (SAA) has a sudden onset, severe symptoms, and progresses rapidly. With deepening understanding and continuous breakthroughs in research, hematopoietic stem cell transplantation (HSCT) has been applied in this field, significantly improving clinical efficacy and prognosis for patients. At the recent 19th National Conference on Red Blood Cell Disorders (Anemia) held in China,…
Connecting Medical Expertise through Media